HBIO
Harvard Bioscience·NASDAQ
--
--(--)
--
--(--)
HBIO fundamentals
Harvard Bioscience (HBIO) released its earnings on Mar 12, 2026: revenue was 23.73M (YoY -3.34%), beat estimates; EPS was 0 (YoY -100.00%), missed estimates.
Revenue / YoY
23.73M
-3.34%
EPS / YoY
0
-100.00%
Report date
Mar 12, 2026
HBIO Earnings Call Summary for Q4,2025
- 2025 Strategic Reset: Refinanced debt, consolidated manufacturing, and appointed new leadership, driving $3M annual cost savings.
- Q4 2025 Strong Performance: $3.8M adjusted EBITDA (27% YoY growth), 60% gross margin, and $23.7M revenue.
- 2026 Growth Outlook: 2-4% revenue growth, 6-10% EBITDA growth, and >10% expansion of new products (BTX, Mesh MEA).
- Key Risks: NIH funding delays, macroeconomic volatility, and tariff impacts in China.
- Financial Health: $6.7M cash flow from operations, net debt reduction to $31.4M, and highest backlog in 2 years.
Earnings
EPS
Revenue
Revenue & Expenses
HBIO has released its 2025 Q4 earnings report, with revenue of 23.73M, reflecting a YoY change of -3.34%, and net profit of -2.85M, showing a YoY change of -15916.67%. The Sankey diagram below clearly presents HBIO's revenue sources and cost distribution.
Key Indicators
Harvard Bioscience (HBIO) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Harvard Bioscience (HBIO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Harvard Bioscience (HBIO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Harvard Bioscience (HBIO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Harvard Bioscience (HBIO) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Harvard Bioscience (HBIO) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the market's earnings forecast for Harvard Bioscience next quarter?What is Harvard Bioscience's gross profit margin?Did Harvard Bioscience beat or miss consensus estimates last quarter?What factors drove the changes in Harvard Bioscience's revenue and profit?What were the key takeaways from Harvard Bioscience's earnings call?What guidance did Harvard Bioscience's management provide for the next earnings period?What were the key takeaways from Harvard Bioscience’s earnings call?What is Harvard Bioscience's latest dividend and current dividend yield?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
